Warby Parker Inc Ordinary Shares - Class A WRBY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WRBY is a good fit for your portfolio.
News
-
Warby Parker's stock sees biggest gain in nearly two years company raises guidance, overshadowing a quarterly loss
-
Warby Parker Announces First Quarter 2024 Results
-
Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024
-
Warby Parker Publishes 2023 Impact Report
-
Warby Parker's stock tumbles again after earnings, as gross margins keep falling
-
Thinking about buying stock in Beneficient, Warby Parker, Akero Therapeutics, Masco, or Nextdoor Holdings?
-
Warby Parker Announces Fourth Quarter and Full Year 2023 Results
-
Warby Parker's stock suffers record selloff as margins were hurt by contact lens sales strength
Trading Information
- Previous Close Price
- $16.14
- Day Range
- $16.03–16.65
- 52-Week Range
- $9.83–16.65
- Bid/Ask
- $16.25 / $17.50
- Market Cap
- $1.96 Bil
- Volume/Avg
- 60 / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 653.41
- Price/Sales
- 2.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,491
- Website
- https://www.warbyparker.com
Comparables
Valuation
|
Metric
|
WRBY
|
FIGS
|
TDUP
|
|---|---|---|---|
Price/Earnings (Normalized) | 653.41 | 51.97 | — |
Price/Book Value | — | 2.51 | 2.44 |
Price/Sales | 2.80 | 1.92 | 0.68 |
Price/Cash Flow | 32.69 | 15.83 | — |
Price/Earnings
WRBY
FIGS
TDUP
Financial Strength
|
Metric
|
WRBY
|
FIGS
|
TDUP
|
|---|---|---|---|
Quick Ratio | 1.72 | 3.68 | 0.90 |
Current Ratio | 2.35 | 5.65 | 1.13 |
Interest Coverage | — | — | −22.95 |
Quick Ratio
WRBY
FIGS
TDUP
Profitability
|
Metric
|
WRBY
|
FIGS
|
TDUP
|
|---|---|---|---|
Return on Assets (Normalized) | 2.08% | 5.01% | −16.80% |
Return on Equity (Normalized) | — | 6.27% | −40.01% |
Return on Invested Capital (Normalized) | 0.96% | 4.00% | −22.19% |
Return on Assets
WRBY
FIGS
TDUP
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Yxpbmsszjn | Hzm | $140.6 Bil | |
BDX
| Becton Dickinson & Co | Spztcbs | Dnjtfv | $68.3 Bil | |
ALC
| Alcon Inc | Rrlqyrh | Pqnvbd | $43.6 Bil | |
RMD
| ResMed Inc | Dnjjdnpc | Hbjwm | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Qvzxnzfhn | Hzdm | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Kghtsxxwl | Dwdj | $26.0 Bil | |
COO
| The Cooper Companies Inc | Sstgnsdx | Svxgslz | $19.3 Bil | |
BAX
| Baxter International Inc | Wdfqbgsn | Bkcpbjp | $18.1 Bil | |
HOLX
| Hologic Inc | Nmqnfjqc | Dfdrr | $17.5 Bil | |
TFX
| Teleflex Inc | Rgb | Rpc | $10.3 Bil |